Amalia GR
Amalia completed her undergraduate degree at the University of Michigan in Biology (Honors) where she graduated with High Distinction and Phi Beta Kappa. She is currently pursuing an MD/MBA at the University of Michigan and will apply into the field of Plastic and Reconstructive Surgery.
Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Elizabeth
Elizabeth is an MD/PhD student at NYU School of Medicine's Medical Scientist Training Program. She holds a BA in Biology with a minor in English from Hunter College.